To review the antidepressant efficacy of S-Adenosyl-L-Methionine (SAMe) both in monotherapy and/or in augmentation with antidepressants to better understand its potential role in the treatment of patients with Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder / De Berardis, Domenico; Orsolini, Laura; Serroni, Nicola; Girinelli, Gabriella; Iasevoli, Felice; Tomasetti, Carmine; DE BARTOLOMEIS, Andrea; Mazza, Monica; Valchera, Alessandro; Fornaro, Michele; Perna, Giampaolo; Piersanti, Monica; Di Nicola, Marco; Cavuto, Marilde; Martinotti, Giovanni; Di Giannantonio, Massimo. - In: CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS. - ISSN 1996-3181. - 15:1(2016), pp. 35-44. [10.2174/1871527314666150821103825]
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder
IASEVOLI, FELICE;TOMASETTI, CARMINE;DE BARTOLOMEIS, ANDREA;Fornaro, Michele;
2016
Abstract
To review the antidepressant efficacy of S-Adenosyl-L-Methionine (SAMe) both in monotherapy and/or in augmentation with antidepressants to better understand its potential role in the treatment of patients with Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).| File | Dimensione | Formato | |
|---|---|---|---|
|
Full-text FINALE.pdf
non disponibili
Tipologia:
Documento in Pre-print
Licenza:
Accesso privato/ristretto
Dimensione
353.59 kB
Formato
Adobe PDF
|
353.59 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
